Patent ID: 11896634
Assignee: BAYLOR COLLEGE OF MEDICINE
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 7:
8. The method according to claim 1, wherein the CAR comprises an antigen binding domain comprising:
a VL domain comprising:
LC-CDR1: SEQ ID NO:10;
LC-CDR2: SEQ ID NO:11;
LC-CDR3: SEQ ID NO:12;

and a VH domain comprising:
HC-CDR1: SEQ ID NO:13;
HC-CDR2: SEQ ID NO:14;
HC-CDR3: SEQ ID NO:15;, or
a VL domain comprising:
LC-CDR1: SEQ ID NO:18;
LC-CDR2: SEQ ID NO:19;
LC-CDR3: SEQ ID NO:20;

and a VH domain comprising:
HC-CDR1: SEQ ID NO:21;
HC-CDR2: SEQ ID NO:22;
HC-CDR3: SEQ ID NO:23;, or
a VL domain comprising:
LC-CDR1: SEQ ID NO:26;
LC-CDR2: SEQ ID NO:27;
LC-CDR3: SEQ ID NO:28;

and a VH domain comprising:
HC-CDR1: SEQ ID NO:29;
HC-CDR2: SEQ ID NO:30;
HC-CDR3: SEQ ID NO:31;, or
a VL domain comprising:
LC-CDR1: SEQ ID NO:57;
LC-CDR2: SEQ ID NO:58;
LC-CDR3: SEQ ID NO:59;

and a VH domain comprising:
HC-CDR1: SEQ ID NO:60;
HC-CDR2: SEQ ID NO:61;
HC-CDR3: SEQ ID NO:62.